Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice

By Joharapurkar Amit   Dhanesha Nirav   Kshirsagar Samadhan   Patel Kartik   Bahekar Rajesh   Shah Gaurang   Jain Mukul  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1009-1015

NRC Research Press

Access to resources Recommend Favorite

Antiobesity effects of chronic cannabinoid CB 1 receptor antagonist treatment in diet-induced obese mice

By Hildebrandt A.L.   Kelly-Sullivan D.M.   Black S.C.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 125-132

Elsevier

Access to resources Recommend Favorite

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats

By Fell M.   Anjum N.   Dickinson K.   Marshall K.   Peltola L.   Vickers S.   Cheetham S.   Neill J.  

Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. : 221-231

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of two Kampo medicines in a diet‐induced mouse obesity model

By  

Traditional & Kampo Medicine, Vol. 2, Iss. 2, 2015-09 ,pp. : 60-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats

By Greene Michael   Thackeray James T.   Kenk Miran   Thorn Stephanie L.   Bevilacqua Lisa   Harper Mary-Ellen   Beanlands Rob S.   DaSilva Jean N.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 3, 2009-03 ,pp. : 196-202

NRC Research Press

Access to resources Recommend Favorite